Acceptance of Chemoprevention by Women at High Risk for Breast Cancer

被引：0
|
作者：
Lane, Karen [1 ]
Hyunh, Kelly [1 ]
Smith, Edie [1 ]
Hsiang, David [1 ]
Butler, John [1 ]
机构：
[1] Univ Calif Irvine, Orange, CA 92668 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2010年 / 17卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [21] Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ
    Reimers, Laura L.
    Sivasubramanian, Parijatham S.
    Hershman, Dawn
    Terry, Mary Beth
    Greenlee, Heather
    Campbell, Julie
    Kalinsky, Kevin
    Maurer, Matthew
    Jayasena, Ramona
    Sandoval, Rossy
    Alvarez, Maria
    Crew, Katherine D.
    BREAST JOURNAL, 2015, 21 (04): : 377 - 386
  • [22] Tamoxifen for breast cancer chemoprevention: Low uptake by high-risk women after evaluation of a breast lump
    Taylor, R
    Taguchi, K
    ANNALS OF FAMILY MEDICINE, 2005, 3 (03) : 242 - 247
  • [23] Comparing Breast Cancer and Cardiovascular Disease Risk and Use of Chemoprevention and Statins among Women with High-risk Breast Lesions
    Lawal, Kehinde O.
    Nilan, Luisa
    Amenta, Jacquelyn
    McGuinness, Julia E.
    Kukafka, Rita
    Crew, Katherine D.
    CANCER PREVENTION RESEARCH, 2023, 16 (12) : 661 - 667
  • [24] Multiple Breast Cancer Risk Factors Do Not Improve Patient Acceptance of Chemoprevention.
    Lo, S. S.
    Henry, E.
    Rychlik, K.
    Mumby, P.
    Bowling, L.
    Robinson, P.
    Albain, K. S.
    CANCER RESEARCH, 2009, 69 (24) : 551S - 551S
  • [25] Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer
    Aktas, Bilge
    Sorkin, Mia
    Pusztai, Lajos
    Hofstatter, Erin W.
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2016, 25 (01) : 3 - 8
  • [26] Uptake of breast cancer chemoprevention among high-risk women and those with ductal carcinoma in situ
    Sivasubramanian, P. S.
    Reimers, L. L.
    Greenlee, H.
    Terry, M. B.
    Hershman, D.
    Maurer, M.
    Kalinsky, K.
    Awad, D.
    Xiao, T.
    Sandoval, R.
    Alvarez, M.
    Quirarte, A.
    Campbell, J.
    Crew, K. D.
    CANCER RESEARCH, 2013, 73
  • [27] Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan
    Kondo, M.
    Hoshi, S-L
    Toi, M.
    BRITISH JOURNAL OF CANCER, 2009, 100 (02) : 281 - 290
  • [28] Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan
    M Kondo
    S-L Hoshi
    M Toi
    British Journal of Cancer, 2009, 100 : 281 - 290
  • [29] Psychosocial compliance and response rates in a chemoprevention randomised control trial of women at high risk to breast cancer
    West, A
    Fallowfield, LJ
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S121 - S121
  • [30] Phase II breast cancer chemoprevention study with celecoxib in women at increased risk for breast cancer.
    Arun, B.
    Valero, V.
    Yin, G.
    Babiera, G.
    Murray, J. L.
    Browne, D.
    Gong, Y.
    Cook, E.
    Hortobagyi, G. N.
    Sneige, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 51S - 51S
12345